Cerbios-Pharma SA (from now on “Cerbios”) has invested in a cGMP atomization plant for particle
engineering using super critical fluid technology capable of generating micro and nano APIs particles with
very narrow particle size distribution.
By the end of 2015 the plant will be fully operative for the handling of HPAIs (High Potency Active
Ingredients) at 200 grams cGMP scale.